These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 486291)

  • 21. A simple micromethod for simultaneous determination of plasma propranolol and 4-hydroxypropranolol.
    Rao PS; Quesada LC; Mueller HS
    Clin Chim Acta; 1978 Sep; 88(2):355-61. PubMed ID: 699330
    [No Abstract]   [Full Text] [Related]  

  • 22. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
    Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
    J Clin Pharmacol; 1993 Aug; 33(8):756-61. PubMed ID: 8408738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic propranolol administration during pregnancy. Maternal pharmacokinetics.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 25(4):481-90. PubMed ID: 6653642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dose and uremia on plasma and urine profiles of propranolol metabolites.
    Schneck DW; Pritchard JF; Gibson TP; Vary JE; Hayes AH
    Clin Pharmacol Ther; 1980 Jun; 27(6):744-55. PubMed ID: 7379441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massive propranolol metabolite retention during maintenance hemodialysis.
    Stone WJ; Walle T
    Clin Pharmacol Ther; 1980 Oct; 28(4):449-55. PubMed ID: 7408404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.
    Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1993; 44(5):489-92. PubMed ID: 8359189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
    Pritchard F; Schneck D; Hayes A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):279-86. PubMed ID: 461953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etintidine-propranolol interaction study in humans.
    Huang SM; Weintraub HS; Marriott TB; Marinan B; Abels R
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):557-68. PubMed ID: 2897462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine.
    Lo MW; Silber B; Riegelman S
    J Chromatogr Sci; 1982 Mar; 20(3):126-31. PubMed ID: 7076780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between plasma propranolol concentration and relief of essential tremor.
    Jefferson D; Jenner P; Marsden CD
    J Neurol Neurosurg Psychiatry; 1979 Sep; 42(9):831-7. PubMed ID: 501384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol in pregnancy three year prospective study.
    Livingstone I; Craswell PW; Bevan EB; Smith MT; Eadie MJ
    Clin Exp Hypertens B; 1983; 2(2):341-50. PubMed ID: 6872291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-methylated catechol-like metabolites of propranolol in man.
    Walle T; Conradi EC; Walle UK; Gaffney TE
    Drug Metab Dispos; 1978; 6(4):481-7. PubMed ID: 28930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Propranolol binding with plasma proteins and erythrocytes].
    Gneushev ET; Mamedov TSh; Gneusheva IA; Sivkov II
    Farmakol Toksikol; 1991; 54(1):55-7. PubMed ID: 1860502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoaffinity isolation of the sulfate conjugate of 4'-hydroxypropranolol from plasma.
    Eller TD; Walle UK; Walle T
    J Chromatogr; 1993 Feb; 612(2):320-5. PubMed ID: 8468392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in blood chemistry in hypertensive patients during propranolol therapy.
    Andreasen F; Jakobsen P; Kornerup HJ; Pedersen EB; Pedersen OL; Weeke J
    Br J Clin Pharmacol; 1984 Mar; 17(3):265-71. PubMed ID: 6712860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations.
    Castleden CM; George CF; Short MD
    Br J Clin Pharmacol; 1978 Feb; 5(2):121-2. PubMed ID: 619945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of propranolol in the human maternal-placental-foetal unit.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 24(6):727-32. PubMed ID: 6884410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of aging on the oxidative and conjugative metabolism of propranolol.
    Tateishi T; Fujimura A; Shiga T; Ohashi K; Ebihara A
    Int J Clin Pharmacol Res; 1995; 15(3):95-101. PubMed ID: 8847155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.